Literature DB >> 26461074

Opioid Induced Hyperalgesia.

Peter Yi1, Peter Pryzbylkowski1.   

Abstract

OBJECTIVE: To discuss the phenomenon of opioid induced hyperalgesia (OIH) and investigate the data and clinical recommendations available on this topic.
DESIGN: A literature search on the topic of OIH was performed. Relevant studies pertaining to OIH were included in this review.
RESULTS: Existing studies and reviews on the pathophysiology, diagnosis, and clinical management of OIH are discussed with updated data and literature references.
CONCLUSION: As more opioids are prescribed, especially to treat chronic nonmalignant pain, OIH becomes more of a relevant and significant issue. Although the exact mechanisms of OIH are not clearly understood further research is required to broaden and develop our knowledge of this topic. Wiley Periodicals, Inc.

Entities:  

Keywords:  Opioid; Opioid Induced Hyperalgesia

Mesh:

Substances:

Year:  2015        PMID: 26461074     DOI: 10.1111/pme.12914

Source DB:  PubMed          Journal:  Pain Med        ISSN: 1526-2375            Impact factor:   3.750


  42 in total

Review 1.  Perioperative Hyperalgesia and Associated Clinical Factors.

Authors:  Obaid S Malik; Alan D Kaye; Richard D Urman
Journal:  Curr Pain Headache Rep       Date:  2017-01

2.  A Practical Approach to Acute Postoperative Pain Management in Chronic Pain Patients.

Authors:  Edwin N Aroke; Susan P McMullan; Katie O Woodfin; Ryan Richey; Jordan Doss; Bryan A Wilbanks
Journal:  J Perianesth Nurs       Date:  2020-07-11       Impact factor: 1.084

3.  Impact of hereditary pancreatitis on patients and their families.

Authors:  Celeste A Shelton; Robin E Grubs; Chandraprakash Umapathy; Dhiraj Yadav; David C Whitcomb
Journal:  J Genet Couns       Date:  2020-02-05       Impact factor: 2.537

4.  Opioids for chronic pain.

Authors:  Marvin Ross
Journal:  CMAJ       Date:  2018-03-05       Impact factor: 8.262

5.  Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

Authors:  Kenneth Blum; Edward J Modestino; Rajendra D Badgaiyan; David Baron; Panayotis K Thanos; Igor Elman; David Siwicki; Marcelo Febo; Mark S Gold
Journal:  EC Psychol Psychiatr       Date:  2018-07-30

Review 6.  Pharmacological Treatment of Pain in Osteoarthritis: A Descriptive Review.

Authors:  Muhammad Hassan Majeed; Syed Ali Amir Sherazi; Douglas Bacon; Zahid H Bajwa
Journal:  Curr Rheumatol Rep       Date:  2018-11-21       Impact factor: 4.592

7.  The conundrum of opioid tapering in long-term opioid therapy for chronic pain: A commentary.

Authors:  Ajay Manhapra; Albert J Arias; Jane C Ballantyne
Journal:  Subst Abus       Date:  2017-10-18       Impact factor: 3.716

8.  Pain distress: the negative emotion associated with procedures in ICU patients.

Authors:  Kathleen A Puntillo; Adeline Max; Jean-Francois Timsit; Stephane Ruckly; Gerald Chanques; Gemma Robleda; Ferran Roche-Campo; Jordi Mancebo; Jigeeshu V Divatia; Marcio Soares; Daniela C Ionescu; Ioana M Grintescu; Salvatore Maurizio Maggiore; Katerina Rusinova; Radoslaw Owczuk; Ingrid Egerod; Elizabeth D E Papathanassoglou; Maria Kyranou; Gavin M Joynt; Gaston Burghi; Ross C Freebairn; Kwok M Ho; Anne Kaarlola; Rik T Gerritsen; Jozef Kesecioglu; Miroslav M S Sulaj; Michelle Norrenberg; Dominique D Benoit; Myriam S G Seha; Akram Hennein; Fernando J Pereira; Julie S Benbenishty; Fekri Abroug; Andrew Aquilina; Julia R C Monte; Youzhong An; Elie Azoulay
Journal:  Intensive Care Med       Date:  2018-08-21       Impact factor: 17.440

9.  Opioid-Induced Hyperalgesic Priming in Single Nociceptors.

Authors:  Eugen V Khomula; Dionéia Araldi; Ivan J M Bonet; Jon D Levine
Journal:  J Neurosci       Date:  2020-11-17       Impact factor: 6.167

10.  Dialectical Pain Management: Feasibility of a Hybrid Third-Wave Cognitive Behavioral Therapy Approach for Adults Receiving Opioids for Chronic Pain.

Authors:  Deborah Barrett; Carrie E Brintz; Amanda M Zaski; Mark J Edlund
Journal:  Pain Med       Date:  2021-05-21       Impact factor: 3.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.